Intensity Therapeutics, Inc.'s Research Selected For Presentation At The 2015 American Association for Cancer Research Annual Meeting

WESTPORT, Conn.--(BUSINESS WIRE)--Intensity Therapeutics, Inc., a privately-held biotechnology company developing proprietary immune-based cancer therapy products, announced that preclinical data using the Company's novel drug product, INT230-6, was selected for presentation at the 2015 American Association for Cancer Research (AACR) Annual Meeting. The conference is being held April 18 to 22, 2015 in the Pennsylvania Convention Center in Philadelphia, PA.

Help employers find you! Check out all the jobs and post your resume.